Treatment for Cutaneous Lymphoma
The team at the Stanford Multidisciplinary Cutaneous Lymphoma Clinic has achieved world-wide recognition for its success in managing patients with cutaneous lymphomas. Their experience includes the use of state-of-the-art treatments, including:
- Topical (nitrogen mustard) and systemic chemotherapy
- Biological therapies, such as interferon and Targretin
- Light therapy, such as PUVA and UVB
- Radiation therapy, including total skin electron beam therapy
Clinical research protocols available to Stanford patients
The Stanford Lymphoma Program has a wide variety of clinical research protocols available for patient management, including a variety of biological therapies such as immune stimulants, monocloncal antibodies, and vaccines. An integral part of our research is to track the long-term outcome of our patients.
Treatment options for cutaneous lymphoma
Treatment for cutaneous lymphoma may include:
- Chemotherapy: Treatment with drugs to destroy cancer cells. Learn more about chemotherapy.
- Other drug therapies (retinoids, targeted drugs, HDAC-inhibitor, folate pathway inhibitors)
- Radiation therapy: Uses a radiation machine that emits X-rays to kill cancer cells and shrink tumors. Learn more about radiation therapy.
- Photodynamic therapy: uses a certain type of light and a special chemical to kill cancer cells. Learn more about photodynamic therapy.
- Extracorporeal photopheresis
Clinical trials are currently being conducted using biological therapy, also called biological response modifier therapy, or immunotherapy. Biological therapy tries to get your own body to fight cancer by using materials made by your own body, or made in a laboratory, to boost, direct, or restore your body's natural defenses against disease.
